• BE Pharmaceuticals AG

    ZG
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-170.3.041.663-0
    Sector: Research and development

    Age of the company

    7 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    3,6 Mio.

    Employees

    PremiumPremium

    Active brands

    0

    Reports for BE Pharmaceuticals AG

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About BE Pharmaceuticals AG

    • BE Pharmaceuticals AG has its legal headquarters in Zug and is active. It is a Company limited by shares (AG) and active in the industry «Research and development».
    • There are 3 active persons registered in the management.
    • All modifications to the commercial register entry can be found under «Notifications». The most recent modification was made on 04.04.2025.
    • The company is registered in the commercial register of the Canton of ZG under the UID CHE-163.345.959.
    • Companies with an identical address: 1M AG, 8TRON AG, A.I.P. Automotive and Industrial Products AG.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Erforschung, Entwicklung, Herstellung, Verkauf und Handel mit pharmazeutischen, biologischen und chemischen Produkten, anderen mit diesen verbundenen Produkten und Gütern aller Art, Erbringung von Dienstleistungen insbesondere im Bereich des Gesundheitswesens sowie Begründung, Erwerb, Verwaltung und Ausgabe von Lizenzen, Patenten und anderen Immaterialgüterrechten; vollständige Zweckumschreibung gemäss Statuten.

    Customise the company purpose with just a few clicks.

    Other company names

    Source: SOGC

    Past and translated company names

    • BE Pharmaceuticals Ltd.
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: BE Pharmaceuticals AG

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250404/2025 - 04.04.2025
    Categories: Change in management

    Publication number: HR02-1006300452, Commercial Registry Office Zug, (170)

    BE Pharmaceuticals AG, in Zug, CHE-163.345.959, Aktiengesellschaft (SHAB Nr. 247 vom 19.12.2024, Publ. 1006209978).

    Ausgeschiedene Personen und erloschene Unterschriften:
    Berger, Naira, von Waldenburg, in Oberengstringen, Mitglied des Verwaltungsrates, mit Einzelunterschrift.

    SOGC 241219/2024 - 19.12.2024
    Categories: Change in capital

    Publication number: HR02-1006209978, Commercial Registry Office Zug, (170)

    BE Pharmaceuticals AG, in Zug, CHE-163.345.959, Aktiengesellschaft (SHAB Nr. 175 vom 10.09.2024, Publ. 1006125859).

    Statutenänderung:
    12.12.2024.

    Aktienkapital neu:
    CHF 3'640'800.00 [bisher: CHF 100'000.00].

    Liberierung Aktienkapital neu:
    CHF 3'640'800.00 [bisher: CHF 100'000.00].

    Aktien neu:
    364'080 Namenaktien zu CHF 10.00 [bisher: 10'000 Namenaktien zu CHF 10.00]. Ordentliche Kapitalerhöhung.

    Qualifizierte Tatbestände neu:
    Ordentliche Kapitalerhöhung durch Umwandlung von frei verwendbarem Eigenkapital. [Ferner Änderung einer nicht publikationspflichtigen Tatsache.]

    SOGC 240910/2024 - 10.09.2024
    Categories: Change of company address, Change in management

    Publication number: HR02-1006125859, Commercial Registry Office Zug, (170)

    BE Pharmaceuticals AG, in Zug, CHE-163.345.959, Aktiengesellschaft (SHAB Nr. 131 vom 09.07.2024, Publ. 1006079440).

    Domizil neu:
    c/o Amicorp Switzerland AG, Baarerstrasse 75, 6300 Zug.

    Eingetragene Personen neu oder mutierend:
    Berger, Naira, von Waldenburg, in Oberengstringen, Mitglied des Verwaltungsrates, mit Einzelunterschrift;
    Pesciatini, Diego, italienischer Staatsangehöriger, in Egg, Mitglied des Verwaltungsrates, mit Einzelunterschrift.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm